Abstract
Inhibitors of interleukin-12/23 (IL-12/23) are compounds which bind to both IL-12 and IL-23 and inactivate them. The major IL-12/23 inhibitor is ustekinumab.
Original language | English |
---|---|
Title of host publication | Compendium of Inflammatory Diseases |
Editors | Michael J. Parnham |
Place of Publication | Switzerland |
Publisher | Springer |
Pages | 714-717 |
Number of pages | 4 |
ISBN (Electronic) | 9783764385507 |
ISBN (Print) | 9783764385309 |
DOIs | |
Publication status | Published - 2016 |
Keywords
- interleukin-12